Not Tagged
Not Tagged
['rectal', 'prospect trial']
#asco23 plenary session underway with results of the prospect trial
x compared neoadjuvant crt vs
folfox
x non-inferioritydfs was met path cr and qol similar x neoadjuvant folfox,with selective use crt,is an effective tx for pts with ct2n+, ct3n-,or ct3n+rectal cancer 
MD @harvard ,MSc medical Oncology, #breastcancer & Researcher American Board Certified.Member of the European Society of Oncology. 𝒞ℴ𝒻𝒻ℯℯ ☕︎♥︎